74 related articles for article (PubMed ID: 35976687)
1. Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital.
Limpawittayakul P; Sungkasubun P; Chaiwiriyawong W; Supavavej A; Weerasubpong B; Siripaibun J; Phanthunane C; Lamlertthon W; Ungtrakul T; Tawinprai K; Tantiyavarong W; Samdaengpan C
Hum Vaccin Immunother; 2022 Nov; 18(6):2104058. PubMed ID: 35976687
[TBL] [Abstract][Full Text] [Related]
2. An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Marchevsky NG; Li G; Aley P; Costa Clemens SA; Barrett JR; Belij-Rammerstorfer S; Bibi S; Clutterbuck E; Dold C; Felle S; Flaxman A; Folegatti P; Jenkin D; Gilbert S; Kelly S; Lambe T; Plested E; Ramasamy M; Singh N; Smith H; Taylor S; Weckx L; Pollard AJ; Voysey M;
EBioMedicine; 2022 Jul; 81():104128. PubMed ID: 35779491
[TBL] [Abstract][Full Text] [Related]
3. A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.
Iwata S; Pollard AJ; Tada Y; Omoto S; Shibata RY; Igarashi K; Hasegawa T; Ariyasu M; Sonoyama T
Sci Rep; 2024 Apr; 14(1):9830. PubMed ID: 38684712
[TBL] [Abstract][Full Text] [Related]
4. Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Kulkarni PS; Padmapriyadarsini C; Vekemans J; Bavdekar A; Gupta M; Kulkarni P; Garg BS; Gogtay NJ; Tambe M; Lalwani S; Singh K; Munshi R; Meshram S; Selvavinayagam TS; Pandey K; Bhimarasetty DM; Ramakrishnan SR; Bhamare C; Dharmadhikari A; Budhawant C; Bonhomme CJ; Thakar M; Kurle SN; Kelly EJ; Gautam M; Gupta N; Panda S; Bhargava B; Poonawalla CS; Shaligram U; Kapse D; Gunale B
Hum Vaccin Immunother; 2024 Dec; 20(1):2304974. PubMed ID: 38512394
[TBL] [Abstract][Full Text] [Related]
5. Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Murray SM; Barbanti M; Campbell C; Brown A; Chen L; Dhanapal J; Tseu B; Pervaiz O; Peters L; Springett S; Danby R; Adele S; Phillips E; Malone T; Amini A; Stafford L; Deeks AS; Dunachie S; Klenerman P; Peniket A; Barnes E; Kesavan M
Br J Haematol; 2022 Aug; 198(4):668-679. PubMed ID: 35655410
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of SARS-CoV-2 Humoral Response Following Vaccination with ChAdOx1 nCoV-19 (Covishield™) and/or Sinopharm, BBIBP-CorV (Vero cell™).
Kamar SB; Pandey H; Shahi R; Puri S; Yadav GK; Amgain K
J Nepal Health Res Counc; 2024 Mar; 21(3):523-529. PubMed ID: 38615227
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Hamaluba M; Sang S; Orindi B; Njau I; Karanja H; Kamau N; Gitonga JN; Mugo D; Wright D; Nyagwange J; Kutima B; Omuoyo D; Mwatasa M; Ngetsa C; Agoti C; Cheruiyot S; Nyaguara A; Munene M; Mturi N; Oloo E; Ochola-Oyier L; Mumba N; Mauncho C; Namayi R; Davies A; Tsofa B; Nduati EW; Aliyan N; Kasera K; Etyang A; Boyd A; Hill A; Gilbert S; Douglas A; Pollard A; Bejon P; Lambe T; Warimwe G;
Wellcome Open Res; 2023; 8():182. PubMed ID: 38707489
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.
Katsuya Y; Yoshida T; Takashima A; Yonemori K; Ohba A; Yazaki S; Yagishita S; Nakahama H; Kobayashi O; Yanagida M; Irino Y; Hamada A; Yamamoto N
Int J Clin Oncol; 2024 Apr; 29(4):386-397. PubMed ID: 38381163
[TBL] [Abstract][Full Text] [Related]
9. Waning of Anti-spike Antibodies in AZD1222 (ChAdOx1) Vaccinated Healthcare Providers: A Prospective Longitudinal Study.
Mishra SK; Pradhan SK; Pati S; Sahu S; Nanda RK
Cureus; 2021 Nov; 13(11):e19879. PubMed ID: 34976499
[TBL] [Abstract][Full Text] [Related]
10. Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production.
Müller M; Volzke J; Subin B; Müller S; Sombetzki M; Reisinger EC; Müller-Hilke B
BMC Med; 2022 Jan; 20(1):29. PubMed ID: 35042529
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh.
Jamiruddin R; Haq A; Khondoker MU; Ali T; Ahmed F; Khandker SS; Jawad I; Hossain R; Ahmed S; Rahman SR; Mustafi M; Kaitsuka T; Mie M; Tomizawa K; Kobatake E; Haque M; Adnan N
Expert Rev Vaccines; 2021 Dec; 20(12):1651-1660. PubMed ID: 34503369
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.
Yasin AI; Aydin SG; Sümbül B; Koral L; Şimşek M; Geredeli Ç; Öztürk A; Perkin P; Demirtaş D; Erdemoglu E; Hacıbekiroglu İ; Çakır E; Tanrıkulu E; Çoban E; Ozcelik M; Çelik S; Teker F; Aksoy A; Fırat ST; Tekin Ö; Kalkan Z; Türken O; Oven BB; Dane F; Bilici A; Isıkdogan A; Seker M; Türk HM; Gümüş M
Future Oncol; 2022 Mar; 18(10):1235-1244. PubMed ID: 35081732
[TBL] [Abstract][Full Text] [Related]
13. Frailty and Humoral Immune Responses Following COVID-19 Vaccination among Patients Undergoing Hemodialysis.
Lin TY; Hung SC
J Nutr Health Aging; 2023; 27(11):980-986. PubMed ID: 37997719
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Clemens SAC; Folegatti PM; Emary KRW; Weckx LY; Ratcliff J; Bibi S; De Almeida Mendes AV; Milan EP; Pittella A; Schwarzbold AV; Sprinz E; Aley PK; Bonsall D; Fraser C; Fuskova M; Gilbert SC; Jenkin D; Kelly S; Kerridge S; Lambe T; Marchevsky NG; Mujadidi YF; Plested E; Ramasamy MN; Simmonds P; Golubchik T; Voysey M; Pollard AJ; ;
Nat Commun; 2021 Oct; 12(1):5861. PubMed ID: 34615860
[TBL] [Abstract][Full Text] [Related]
15. Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.
Maaske J; Sproule S; Falsey AR; Sobieszczyk ME; Luetkemeyer AF; Paulsen GC; Riddler SA; Robb ML; Rolle CP; Sha BE; Tong T; Ahani B; Aksyuk AA; Bansal H; Egan T; Jepson B; Padilla M; Patel N; Shoemaker K; Stanley AM; Swanson PA; Wilkins D; Villafana T; Green JA; Kelly EJ
Front Immunol; 2022; 13():1062067. PubMed ID: 36713413
[TBL] [Abstract][Full Text] [Related]
16. AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Meeraus W; Joy M; Ouwens M; Taylor KS; Venkatesan S; Dennis J; Tran TN; Dashtban A; Fan X; Williams R; Morris T; Carty L; Kar D; Hoang U; Feher M; Forbes A; Jamie G; Hinton W; Sanecka K; Byford R; Anand SN; Hobbs FDR; Clifton DA; Pollard AJ; Taylor S; de Lusignan S
J Infect; 2024 Apr; 88(4):106129. PubMed ID: 38431156
[TBL] [Abstract][Full Text] [Related]
17. Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine.
Chavan A; Shriyan B; Chavan P; Shirsat A; Gavhane U; Pillai B; Bhat V; Dhamne C; Gota V
South Asian J Cancer; 2024 Jan; 13(1):33-37. PubMed ID: 38721108
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of COVID-19 Vaccines in Patients with Hematological Malignancy Compared to Healthy Controls: A Systematic Review and Meta-analysis.
Das Barshan A; Matsumoto-Takahashi ELA
JMA J; 2024 Apr; 7(2):153-171. PubMed ID: 38721084
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of hepatitis A antibody after immunization with hepatitis A vaccine (Aimmugen) in people living with HIV.
Koga M; Saito M; Kubota M; Senkoji T; Adachi E; Ikeuchi K; Kikuchi T; Otani A; Takahashi K; Tsutsumi T; Yotsuyanagi H
Hepatol Res; 2024 May; 54(5):487-494. PubMed ID: 38263905
[TBL] [Abstract][Full Text] [Related]
20. Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Ewer KJ; Barrett JR; Belij-Rammerstorfer S; Sharpe H; Makinson R; Morter R; Flaxman A; Wright D; Bellamy D; Bittaye M; Dold C; Provine NM; Aboagye J; Fowler J; Silk SE; Alderson J; Aley PK; Angus B; Berrie E; Bibi S; Cicconi P; Clutterbuck EA; Chelysheva I; Folegatti PM; Fuskova M; Green CM; Jenkin D; Kerridge S; Lawrie A; Minassian AM; Moore M; Mujadidi Y; Plested E; Poulton I; Ramasamy MN; Robinson H; Song R; Snape MD; Tarrant R; Voysey M; Watson MEE; Douglas AD; Hill AVS; Gilbert SC; Pollard AJ; Lambe T;
Nat Med; 2021 Jun; 27(6):1116. PubMed ID: 34021278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
